Role of Fatty Acid Binding Protein 1 in Non- Alcoholic Fatty Pancreatic Disease with and without Diabetes Mellitus

Liver Fatty Acid-binding Protein (L-FABP) as a Diagnostic Marker for Non-alcoholic Fatty Liver Disease

Role of Activin A as A Novel Marker for Diagnosis and Evaluation of Nonalchoholic Fatty Liver Disease

Role of Fetuin-A as a Noninvasive Biomarker in Diagnosis and Assessment of Severity of Non-Alcoholic Fatty Liver Disease.

Role of Circulating Vascular Cell Adhesion Protein–1 as a Biomarker in Non-Alcoholic Fatty Liver Disease

Studying the Association between Non Alcoholic Fatty Pancreatic Disease and Non Alcoholic Fatty Liver Disease

Chemerin As A Non-Invasive Serum Marker for Non-Alcoholic Fatty Liver Disease

Study of Fatty Acid Binding Protein 4 (FABP4) levels in Patients with Beta-thalassemia and its Related Complications...

STUDYING THE ASSOCIATION BETWEEN NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC FATTY PANCREAS DISEASE USING TRANSABDOMINAL ULTRASOUND AND ENDOSCOPIC ULTRASOUND

Prognostic value of liver fatty acid-binding protein (FABPs) for impairment of renal function in type2 diabetic (T2D) patients